Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy vs Standard Chemoradiotherapy in Advanced Oropharyngeal Cancer
NCT00268372Phase 3Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Dec 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, fluorouracil in squamous cell carcinoma of the oropharynx (OPSCC), sponsored by SWOG Cancer Research Network. Started Dec 2005; status: terminated.
02
Drugs
docetaxelfluorouracil
03
Conditions
squamous cell carcinoma of the oropharynx (OPSCC)
Beyond the preview
Go deeper on NCT00268372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268372.